GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » hVIVO PLC (LSE:HVO) » Definitions » Price-to-Owner-Earnings

hVIVO (LSE:HVO) Price-to-Owner-Earnings : 8.87 (As of May. 29, 2024)


View and export this data going back to 2012. Start your Free Trial

What is hVIVO Price-to-Owner-Earnings?

As of today (2024-05-29), hVIVO's share price is £0.266. hVIVO's Owner Earnings per Share (TTM) ended in Dec. 2023 was £0.03. It's Price-to-Owner-Earnings for today is 8.87.


The historical rank and industry rank for hVIVO's Price-to-Owner-Earnings or its related term are showing as below:

LSE:HVO' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 7.81   Med: 15.31   Max: 128.22
Current: 8.36

During the past 13 years, the highest Price-to-Owner-Earnings of hVIVO was 128.22. The lowest was 7.81. And the median was 15.31.


LSE:HVO's Price-to-Owner-Earnings is ranked better than
88.89% of 162 companies
in the Biotechnology industry
Industry Median: 33.475 vs LSE:HVO: 8.36

As of today (2024-05-29), hVIVO's share price is £0.266. hVIVO's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was £0.02. Therefore, hVIVO's PE Ratio for today is 11.08.

As of today (2024-05-29), hVIVO's share price is £0.266. hVIVO's EPS without NRI for the trailing twelve months (TTM) ended in was £0.01. Therefore, hVIVO's PE Ratio without NRI for today is 20.46.

During the past 13 years, hVIVO's highest PE Ratio without NRI was 87.22. The lowest was 13.00. And the median was 21.96.


hVIVO Price-to-Owner-Earnings Historical Data

The historical data trend for hVIVO's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

hVIVO Price-to-Owner-Earnings Chart

hVIVO Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 76.93 - 7.69 7.42

hVIVO Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 7.69 - 7.42

Competitive Comparison of hVIVO's Price-to-Owner-Earnings

For the Biotechnology subindustry, hVIVO's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


hVIVO's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, hVIVO's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where hVIVO's Price-to-Owner-Earnings falls into.



hVIVO Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

hVIVO's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=0.266/0.03
=8.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


hVIVO  (LSE:HVO) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


hVIVO Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of hVIVO's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


hVIVO (LSE:HVO) Business Description

Industry
Traded in Other Exchanges
Address
42, New Road, Queen Mary Bioenterprises Innovation Centre, London, GBR, E1 2AX
hVIVO PLC is a European-focused, rare, and orphan drug consulting services platform. The principal activity of the Group is that of a rapidly growing specialist CRO pharmaceutical services company, which involves the testing of vaccines and antivirals using human-challenge clinical trials. The group is also engaged in Venn Life Sciences' Clinical Research Division, providing a suite of consulting and clinical trial services to pharmaceutical, biotechnology, and medical device organizations.

hVIVO (LSE:HVO) Headlines

No Headlines